Sutro Biopharma, Inc. (STRO)
15.05
-1.27
(-7.78%)
USD |
NASDAQ |
Jan 23, 16:00
15.00
-0.05
(-0.33%)
After-Hours: 20:00
Sutro Biopharma Research and Development Expense (TTM): 200.81M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GT Biopharma, Inc. | 4.026M |
| Daré Bioscience, Inc. | 6.616M |
| Syndax Pharmaceuticals, Inc. | 245.67M |
| Rhythm Pharmaceuticals, Inc. | 165.86M |
| Crinetics Pharmaceuticals, Inc. | 309.89M |